Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Paolo Solidoro, Filippo Patrucco & Diego Bagnasco. (2019) Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review. Expert Review of Respiratory Medicine 13:11, pages 1087-1094.
Read now
Read now
Krithika Rajagopalan, Lisa Bloudek, Jessica Marvel, Carole Dembek & Abhishek Kavati. (2018) Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3867-3877.
Read now
Read now
James F Donohue, Keith A Betts, Ella Xiaoyan Du, Pablo Altman, Pankaj Goyal, Dorothy L Keininger, Jean-Bernard Gruenberger & James E Signorovitch. (2017) Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 367-381.
Read now
Read now
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel. (2016) Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 167-192.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2015) Indacaterol for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:1, pages 107-115.
Read now
Read now
James F Donohue. (2014) Systematic review comparing LABA, olodaterol, and indacaterol: limitations. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1331-1335.
Read now
Read now
Neil S Roskell, Antonio Anzueto, Alan Hamilton, Bernd Disse & Karin Becker. (2014) Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 813-824.
Read now
Read now
Andrea Rossi & Guido Polese. (2013) Indacaterol: a comprehensive review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 353-363.
Read now
Read now
Shannon Cope, Matthias Kraemer, Jie Zhang, Gorana Capkun-Niggli & Jeroen P Jansen. (2012) Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 415-420.
Read now
Read now
Articles from other publishers (9)
Jeffrey J Swigris, Dirk Esser, Craig S Conoscenti & Kevin K Brown. (2014) The psychometric properties of the St George’s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health and Quality of Life Outcomes 12:1.
Crossref
Crossref
Girolamo Pelaia, Rosario Maselli & Maria Gabriella Matera. (2014) Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium. Pharmacology 94:5-6, pages 249-258.
Crossref
Crossref
Shannon Cope, James F Donohue, Jeroen P Jansen, Matthias Kraemer, Gorana Capkun-Niggli, Michael Baldwin, Felicity Buckley, Alexandra Ellis & Paul Jones. (2013) Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis. Respiratory Research 14:1.
Crossref
Crossref
Shannon Cope, Jie Zhang, James Williams & Jeroen P Jansen. (2012) Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis. BMC Pulmonary Medicine 12:1.
Crossref
Crossref
Juan Guillermo Ariza, Per-Olof Thuresson, Gerardo Machnicki, Laura Mungapen, Matthias Kraemer, Yumi Asukai & Luis Fernando Giraldo. (2012) The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System. Value in Health Regional Issues 1:2, pages 165-171.
Crossref
Crossref
Mark Kagan, Jeremy Dain, Lana Peng & Christine Reynolds. (2012) Metabolism and Pharmacokinetics of Indacaterol in Humans. Drug Metabolism and Disposition 40:9, pages 1712-1722.
Crossref
Crossref
Mario Cazzola, Clive P. Page, Luigino Calzetta & M. Gabriella Matera. (2012) Pharmacology and Therapeutics of Bronchodilators. Pharmacological Reviews 64:3, pages 450-504.
Crossref
Crossref
Kate McKeage. (2012) Indacaterol. Drugs 72:4, pages 543-563.
Crossref
Crossref
Roberto Stirbulov & Fernando Luiz Cavalcanti Lundgren. (2011) Terapêutica medicamentosa da DPOC. Jornal Brasileiro de Pneumologia 37:4, pages 419-421.
Crossref
Crossref